Johan Schultz, PhD, born 1960, is Vice President Research & Development Operations, responsible for preclinical development and R&D Operations. Schultz has more than 30 years of combined experience in academic research in the pharmaceutical industry. Schultz holds a Bachelor of Science degree in chemistry from the University of Uppsala and a PhD in physical chemistry from the University of Stockholm. Joined Kancera in 2013 and appointed as VP R&D Operations in 2024.
Back